These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 14601962

  • 1. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y, Zhao F, Paborji M.
    Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
    [Abstract] [Full Text] [Related]

  • 2. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F, Jones BE.
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
    [Abstract] [Full Text] [Related]

  • 3. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M, Li W, Dulin W, Donahue F, Cade D, Benameur H, Hutchison K.
    Int J Pharm; 2010 Feb 15; 386(1-2):30-41. PubMed ID: 19900518
    [Abstract] [Full Text] [Related]

  • 4. HPMC capsules: current status and future prospects.
    Al-Tabakha MM.
    J Pharm Pharm Sci; 2010 Feb 15; 13(3):428-42. PubMed ID: 21092714
    [Abstract] [Full Text] [Related]

  • 5. The shell dissolution of various empty hard capsules.
    Chiwele I, Jones BE, Podczeck F.
    Chem Pharm Bull (Tokyo); 2000 Jul 15; 48(7):951-6. PubMed ID: 10923822
    [Abstract] [Full Text] [Related]

  • 6. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D, Bindra DS.
    Pharm Dev Technol; 2007 Jul 15; 12(1):71-7. PubMed ID: 17484146
    [Abstract] [Full Text] [Related]

  • 7. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M, Rothenhäusler B, Röthlisberger D.
    Drug Dev Ind Pharm; 2006 Jul 15; 32(10):1165-73. PubMed ID: 17090439
    [Abstract] [Full Text] [Related]

  • 8. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM, Arida AI, Fahelelbom KM, Sadek B, Saeed DA, Abu Jarad RA, Jawadi J.
    Drug Dev Ind Pharm; 2015 Jul 15; 41(10):1726-37. PubMed ID: 25586554
    [Abstract] [Full Text] [Related]

  • 9. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
    El-Malah Y, Nazzal S, Bottom CB.
    Drug Dev Ind Pharm; 2007 Jan 15; 33(1):27-34. PubMed ID: 17192248
    [Abstract] [Full Text] [Related]

  • 10. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
    Ku MS, Lu Q, Li W, Chen Y.
    Int J Pharm; 2011 Sep 15; 416(1):16-24. PubMed ID: 21356291
    [Abstract] [Full Text] [Related]

  • 11. 3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen.
    Gaurkhede SG, Osipitan OO, Dromgoole G, Spencer SA, Pasqua AJD, Deng J.
    J Pharm Sci; 2021 Dec 15; 110(12):3829-3837. PubMed ID: 34469748
    [Abstract] [Full Text] [Related]

  • 12. Gelatin and Non-Gelatin Capsule Dosage Forms.
    Gullapalli RP, Mazzitelli CL.
    J Pharm Sci; 2017 Jun 15; 106(6):1453-1465. PubMed ID: 28209365
    [Abstract] [Full Text] [Related]

  • 13. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M, Mercuri A, Naylor TA, Rizzo D, Butler JM, Connolly PC, Wickham MS, Faulks RM.
    Int J Pharm; 2011 Oct 31; 419(1-2):192-9. PubMed ID: 21843611
    [Abstract] [Full Text] [Related]

  • 14. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
    Barbosa JAC, Al-Kauraishi MM, Smith AM, Conway BR, Merchant HA.
    Eur J Pharm Biopharm; 2019 Nov 31; 144():174-179. PubMed ID: 31541663
    [Abstract] [Full Text] [Related]

  • 15. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations.
    Honkanen O, Laaksonen P, Marvola J, Eerikäinen S, Tuominen R, Marvola M.
    Eur J Pharm Sci; 2002 Jun 31; 15(5):479-88. PubMed ID: 12036724
    [Abstract] [Full Text] [Related]

  • 16. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
    Curatolo W, Liu P, Johnson BA, Hausberger A, Quan E, Vendola T, Vatsaraj N, Foulds G, Vincent J, Chandra R.
    Pharm Res; 2011 Jul 31; 28(7):1531-9. PubMed ID: 21331473
    [Abstract] [Full Text] [Related]

  • 17. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC, Podczeck F, Turnbull N.
    Int J Pharm; 2004 Nov 05; 285(1-2):51-63. PubMed ID: 15488679
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET, Scott RA, Cade D, Connor AL, Wilding IR.
    Pharm Res; 2004 May 05; 21(5):793-8. PubMed ID: 15180336
    [Abstract] [Full Text] [Related]

  • 19. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.
    Abd El-Sattar Fahmy S, Christensen JM, Ayres JW.
    Drug Dev Ind Pharm; 2009 Aug 05; 35(8):1009-21. PubMed ID: 19274589
    [Abstract] [Full Text] [Related]

  • 20. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells.
    Zhao F, Malayev V, Rao V, Hussain M.
    Pharm Res; 2004 Jan 05; 21(1):144-8. PubMed ID: 14984269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.